It’s a privilege to have met Daniel O’Day again, Chairman & CEO of Gilead Sciences Inc. at a meeting post CROI 2025 in Forster City, CA. Our conversation highlighted the importance of continued innovation and collaboration in HIV prevention and treatment. Truly inspiring to see high level leadership committed to improving global health!
